{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T15:37:35Z","timestamp":1781710655564,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-026-09425-9","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T09:54:52Z","timestamp":1767952492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Piperacillin-tazobactam\/meropenem vs colistin\/meropenem for carbapenem-resistant Klebsiella Pneumoniae-related ventilator-associated pneumonia"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0229-575X","authenticated-orcid":false,"given":"Mohammad Mehdi","family":"Shadravan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9127-9470","authenticated-orcid":false,"given":"Farid","family":"Javandoust Gharehbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-8031","authenticated-orcid":false,"given":"Mohamad Amin","family":"Pourhoseingholi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1201-5929","authenticated-orcid":false,"given":"Somaye","family":"Jahanabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-7104","authenticated-orcid":false,"given":"Lida","family":"Lotfollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4440-335X","authenticated-orcid":false,"given":"Ilad","family":"Alavi Darazam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"issue":"1","key":"9425_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12010213","volume":"12","author":"M Miron","year":"2024","unstructured":"Miron M, Blaj M, Ristescu AI, Iosep G, Av\u0103danei AN, Iosep DG, et al. Hospital-acquired pneumonia and ventilator-associated pneumonia: a literature review. Microorganisms. 2024;12(1):213.","journal-title":"Microorganisms"},{"issue":"1","key":"9425_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02840-x","volume":"23","author":"E Abbasi","year":"2023","unstructured":"Abbasi E, Ghaznavi-Rad E. High frequency of NDM-1 and OXA-48 carbapenemase genes among Klebsiella pneumoniae isolates in central Iran. BMC Microbiol. 2023;23(1):98.","journal-title":"BMC Microbiol"},{"issue":"5","key":"9425_CR3","volume":"15","author":"F Ghanbarinasab","year":"2023","unstructured":"Ghanbarinasab F, Haeili M, Ghanati SN, Moghimi M. High prevalence of OXA-48-like and NDM carbapenemases among carbapenem resistant Klebsiella pneumoniae of clinical origin from Iran. Iran J Microbiol. 2023;15(5):609.","journal-title":"Iran J Microbiol"},{"issue":"1","key":"9425_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-022-06407-5","volume":"23","author":"L Hu","year":"2022","unstructured":"Hu L, Peng K, Huang X, Wang Z, Wu Q, Xiao Y, et al. Ventilator-associated pneumonia prevention in the Intensive care unit using Postpyloric tube feeding in China (VIP study): study protocol for a randomized controlled trial. Trials. 2022;23(1):478.","journal-title":"Trials"},{"issue":"1","key":"9425_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50805-z","volume":"15","author":"F Howroyd","year":"2024","unstructured":"Howroyd F, Chacko C, MacDuff A, Gautam N, Pouchet B, Tunnicliffe B, et al. Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges. Nat Commun. 2024;15(1):6447.","journal-title":"Nat Commun"},{"issue":"2","key":"9425_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1055\/s-0041-1740605","volume":"43","author":"M Bassetti","year":"2022","unstructured":"Bassetti M, Mularoni A, Giacobbe DR, Castaldo N, Vena A. New antibiotics for hospital-acquired pneumonia and ventilator-associated pneumonia. Semin Respir Crit Care Med. 2022;43(2):280\u201394.","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"9425_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jiph.2012.02.003","volume":"5","author":"RI El-Herte","year":"2012","unstructured":"El-Herte RI, Kanj SS, Matar GM, Araj GF. The threat of carbapenem-resistant Enterobacteriaceae in Lebanon: an update on the regional and local epidemiology. J Infect Public Health. 2012;5(3):233\u201343.","journal-title":"J Infect Public Health"},{"issue":"3","key":"9425_CR8","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318\u201327.","journal-title":"Lancet Infect Dis"},{"key":"9425_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127249","volume":"266","author":"J Ma","year":"2023","unstructured":"Ma J, Song X, Li M, Yu Z, Cheng W, Yu Z, et al. Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy. Microbiol Res. 2023;266:127249.","journal-title":"Microbiol Res"},{"key":"9425_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00262","volume":"10","author":"B Gao","year":"2019","unstructured":"Gao B, Li X, Yang F, Chen W, Zhao Y, Bai G, et al. Molecular Epidemiology and Risk Factors of Ventilator-Associated Pneumonia Infection Caused by Carbapenem-Resistant Enterobacteriaceae. Front Pharmacol. 2019;10:262.","journal-title":"Front Pharmacol"},{"issue":"11","key":"9425_CR11","doi-asserted-by":"publisher","first-page":"e943","DOI":"10.1016\/S2666-5247(23)00208-2","volume":"4","author":"JK Calland","year":"2023","unstructured":"Calland JK, Haukka K, Kpordze SW, Brusah A, Corbella M, Merla C, et al. Population structure and antimicrobial resistance among Klebsiella isolates sampled from human, animal, and environmental sources in Ghana: a cross-sectional genomic One Health study. Lancet Microbe. 2023;4(11):e943\u201352.","journal-title":"Lancet Microbe"},{"issue":"6b","key":"9425_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0002-9343(86)90476-6","volume":"80","author":"P DeJace","year":"1986","unstructured":"DeJace P, Klastersky J. Comparative review of combination therapy: two beta-lactams versus beta-lactam plus aminoglycoside. Am J Med. 1986;80(6b):29\u201338.","journal-title":"Am J Med"},{"key":"9425_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-017-1769-z","volume":"21","author":"G De Pascale","year":"2017","unstructured":"De Pascale G, Martucci G, Montini L, Panarello G, Cutuli SL, Di Carlo D, et al. Double carbapenem as a rescue strategy for the treatment of severe carbapenemase-producing Klebsiella pneumoniae infections: a two-center, matched case\u2013control study. Crit Care. 2017;21:1\u201310.","journal-title":"Crit Care"},{"issue":"12","key":"9425_CR14","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/jac\/dkz389","volume":"74","author":"A Lawandi","year":"2019","unstructured":"Lawandi A, Leite G, Cheng MP, Lefebvre B, Longtin J, Lee TC. In vitro synergy of \u03b2-lactam combinations against KPC-producing Klebsiella pneumoniae strains. J Antimicrob Chemother. 2019;74(12):3515\u201320.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"9425_CR15","doi-asserted-by":"publisher","first-page":"02317","DOI":"10.1128\/aac","volume":"65","author":"A Lawandi","year":"2021","unstructured":"Lawandi A, Leite GC, Cheng MP, Lefebvre B, Longtin J, Lee TC. Assessment of piperacillin-tazobactam-meropenem synergy against serine carbapenemase-producing Enterobacterales using Time-Kill assays. Antimicrobial Agents Chemother. 2021;65(4):02317\u201320. https:\/\/doi.org\/10.1128\/aac.","journal-title":"Antimicrobial Agents Chemother"},{"issue":"1","key":"9425_CR16","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/jac\/dkv294","volume":"71","author":"L Poirel","year":"2016","unstructured":"Poirel L, Kieffer N, Nordmann P. In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2016;71(1):156\u201361.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"9425_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"A-W Chan","year":"2013","unstructured":"Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158(3):200\u20137.","journal-title":"Ann Intern Med"},{"issue":"5","key":"9425_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/j.pbj.0000000000000189","volume":"7","author":"D Guerra","year":"2022","unstructured":"Guerra D, Vidal P, Paccoud O, Maillard A, Cachera L, Junot H, et al. Dual beta-lactam treatment: pros and cons. Porto Biomed J. 2022;7(5):e189.","journal-title":"Porto Biomed J"},{"issue":"5_pt_1","key":"9425_CR19","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1121","volume":"143","author":"J Pugin","year":"1991","unstructured":"Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic \u201cblind\u201d bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143(5_pt_1):1121\u20139.","journal-title":"Am Rev Respir Dis"},{"key":"9425_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jgar.2018.07.003","volume":"15","author":"MFA Abdelsalam","year":"2018","unstructured":"Abdelsalam MFA, Abdalla MS, El-Abhar HSED. Prospective, comparative clinical study between high-dose colistin monotherapy and colistin\u2013meropenem combination therapy for treatment of hospital-acquired pneumonia and ventilator-associated pneumonia caused by multidrug-resistant Klebsiella pneumoniae. J Glob Antimicrob Resist. 2018;15:127\u201335.","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"9425_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1177\/0018578720985436","volume":"57","author":"ML Bianchini","year":"2022","unstructured":"Bianchini ML, Jeffres MN, Campbell JD. Cost-effectiveness analysis of new beta-lactam beta-lactamase inhibitor antibiotics versus colistin for the treatment of carbapenem-resistant infections. Hosp Pharm. 2022;57(1):93\u2013100.","journal-title":"Hosp Pharm"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-026-09425-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-026-09425-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T23:03:33Z","timestamp":1771283013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13063-026-09425-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9425"],"URL":"https:\/\/doi.org\/10.1186\/s13063-026-09425-9","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The equal contribution note was added.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Shahid Beheshti University of Medical Sciences (Code: IR.SBMU.RETECH.REC.1403.571; available at:\n                      \n                      ). All participants will sign a written informed consent form by the main researcher. For patients who are sedated or mechanically ventilated and unable to provide consent, proxy consent will be obtained from a legally authorized representative (next of kin or guardian), and informed consent will be reaffirmed with the patient once they regain capacity. The results of this study will be disseminated in a medical journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}